Ibrahim Aldoss

52PUBLICATIONS
151CO-AUTHORS
Haematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jul 24, 2026
B-cell activating factor receptor expression in B-lymphoblastic leukaemia: Flow cytometric analysis and implications for targeted therapy.

|Mar 30, 2026
Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL.

Caner Saygin, Matthew T Witkowski, Sinan Cetin

|Feb 20, 2026
Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy.

Lior Goldberg, Eric R Haas, Jiaqi Wu

|Nov 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki

|Oct 11, 2025
Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations.

Ibrahim Aldoss, Amir Ali, Ryan D Cassaday

|Sep 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.

Jose Tinajero, Kim Nguyen, Dat Ngo

Pageof 9

Frequent Collaborators

20 joint publications

Paul Koller

20 joint publications

Vinod Pullarkat

17 joint publications

Monzr M Al-Malki

16 joint publications

Amandeep Salhotra